Skip to main content
. 2017 Sep 4;214(9):2795–2810. doi: 10.1084/jem.20161955

Figure 2.

Figure 2.

B7 on DCs but not B cells is critical for TD antigen–specific IgG1 production. (A) Generation of B7.1flox mice. LoxP sites were inserted to flox exon 2 of the B7.1 gene on the BAC. B7.1flox BAC Tg mice were backcrossed to B7.1−/− B7.2−/− DKO mice to eliminate endogenous B7.1 and B7.2 expression. B7.1flox Tg-B7 DKO mice expressed B7.1 on splenic DCs at a level similar to that of WT B6 mice before and after LPS stimulation in vitro. Data are representative of at least three independent experiments. (B) B7.1 expression on DCs and B cells of DC-specific and B cell–specific B7 cKO mice. Splenocytes were stimulated with ConA/LPS/IL-2 for 24 h, and B7.1 expression on DCs (CD11chigh) and B cells (B220+) was analyzed. Shaded histograms indicate anti-B7.1 antibody staining of B7 cKO strains, and dashed lines indicate anti-B7.1 staining of B7.1/B7.2 DKO mice. Numbers indicate percentages of B7.1+ cells. Data are representative of three independent experiments. (C) Antigen-specific IgG1 production by B7 cKO strains. B7 cKO mice were immunized with NP-KLH/Alum. At 3 wk after immunization, serum anti-NP IgG1 titer was analyzed by ELISA. Dashed line indicates background OD value in empty wells. Each strain, n = 3. Data are representative of three independent experiments. ns, not significant. (D) Antibody affinity maturation was determined by ratio of high-affinity NP-specific IgG1 (measured by binding to NP4-BSA) to total NP-specific IgG1 (measured by binding to NP25-BSA) in serum at 7, 21, and 63 d after immunization. B7.1flox, n = 5; BC-B7cKO, n = 6 for day 7 and day 21 and n = 3 at day 63. Data are representative of three independent experiments. (E) NP-specific GC B cell development in B7 cKO strains. B7 cKO strains were immunized with NP-KLH/Alum. 1 wk after immunization, NP-binding GC B cells (B220+ GL7+ Fas+ NP-PE+) in the spleen were determined by flow cytometry. Data presented are the combined result of three independent experiments. The total numbers of mice in the three combined experiments are B7.1flox, n = 8; B7 DKO, n = 8; DC-B7 cKO, n = 6; and BC-B7 cKO, n = 8. (F) 1 wk after NP-KLH/Alum immunization, B7.1 expression on GC B cells was analyzed. Shaded histograms indicate anti-B7.1 staining, and dashed lines indicate isotype control staining. Data are representative of three independent experiments. (G) NP-specific GC B cell development in B cell–specific B7-deficient BM chimeras. BM chimeras were made that were completely and specifically deficient in expression of B7 on B cells by reconstitution of B cell KO hosts with a mixture of B7 DKO BM and B cell KO (μMT) BM (B7.1−/− B7.2−/− + μMT). Control chimeras were reconstituted with a mixture of B7 WT BM and B cell KO (μMT) BM (B7.1+/+ B7.2+/+ + μMT). Chimeras were immunized with NP-KLH/Alum. 1 wk after immunization, NP-binding GC B cells (B220+ GL7+ CD38dull NP-PE+ IgG1+) in the spleen were determined by flow cytometry. Each group, n = 3. Data are representative of two independent experiments. Statistical significance was determined by Student’s t test for single comparison or one-way ANOVA followed by Dunnett’s method for multiple comparisons. All error bars represent the mean ± SEM.